Results 181 to 190 of about 2,436,024 (405)

Global Oncology [PDF]

JAMA, 2019
Gopal, Satish, Loehrer, Patrick J., Sr.
openaire   +2 more sources

Harnessing multimodal data integration to advance precision oncology

Nature Reviews. Cancer, 2021
K. Boehm, Pegah Khosravi, R. Vanguri, Jianjiong Gao, Sohrab P. Shah   +4 more
semanticscholar   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Correction: Addendum of Informed Consent Statements [PDF]

Journal of Urologic Oncology
Editorial Office, Korean Urological Oncology Society
doaj   +1 more source

Expert Consensus of Multidisciplinary Treatment on Bone Metastasis of Prostate Cancer(Version 2020)

Zhongliu Fangzhi Yanjiu, 2020
Prostate Cancer Group, Chinese Anticancer Association Genitourinary Oncology Committee
doaj   +1 more source

Artificial intelligence for multimodal data integration in oncology.

Cancer Cell, 2022
Jana Lipková, Richard J. Chen, Bowen Chen, Ming Y. Lu, Matteo Barbieri, Daniel Shao, Anurag Vaidya, Chengkuan Chen, Luoting Zhuang, Drew F. K. Williamson, M. Shaban, Tiffany Y. Chen, Faisal Mahmood   +12 more
semanticscholar   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report [PDF]

Journal of Urologic Oncology
Editorial Office, Korean Urological Oncology Society
doaj   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Repurposing non-cancer drugs in oncology: Aspirin and metformin are only the tip of the iceberg [PDF]

, 2017
Bishal Gyawali, Pan Pantziarka, Lydie Meheus, Gauthier Bouche   +3 more
openalex   +1 more source